Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Commercialization

<< Previous

Bullboard Posts

Next >>

Comment by EduardoSanchezon Feb 16, 2020 11:57am

129 Views

Post# 30697205

RE:RE:Commercialization

Lex will be acquired. They have been quite clear about this. The potential market $, lowest cost/test, high margins, razor blade model, gold standard sensitivity and time to results... Big Bio with existing sales channel will turn this into massive profits quickly. There is currently lots of interest from big bio. Recent contact from another big co that is a new one into the mix. Gearing up for multi bidders. Once the commercial unit is unveiled lab visits will be starting for acquirers to view and test.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments